ID
25312
Beskrivning
Study part: Significant Medical/ Surgical History And Physical Examination Screening. A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Phase: phase 1. Study Recruitment Status: Completed Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/201. Clinical Study ID: 101468/201
Nyckelord
Versioner (4)
- 2017-09-01 2017-09-01 -
- 2019-06-18 2019-06-18 -
- 2019-06-18 2019-06-18 -
- 2021-09-17 2021-09-17 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
1 september 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Significant Medical/ Surgical History And Physical Examination Screening Ropinirole Restless Legs Syndrome 101468/201
Significant Medical/ Surgical History And Physical Examination Screening
Similar models
Significant Medical/ Surgical History And Physical Examination Screening
C0031809 (UMLS CUI-2)
C0543467 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
Inga kommentarer